Peter Cage

FPL 66096: a novel, highly potent and selective antagonist at human platelet P_2T‐purinoceptors

Robert G. Humphries, Wendy Tomlinson, Anthony H. Ingall et al. · British Journal of Pharmacology · 1994 · 98 citations · Full text

Medicine, Biochemistry, Pharmacology +15

QSAR and the Rational Design of Long-Acting Dual D₂-Receptor/β₂-Adrenoceptor Agonists

Rupert P. Austin, Patrick Barton, Roger V. Bonnert et al. · Journal of Medicinal Chemistry · 2003 · 65 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Evaluation of a series of bicyclic CXCR2 antagonists

Iain A. S. Walters, Caroline A. Austin, Rupert P. Austin et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 62 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate

Mark Furber, A.K. Tiden, Philip Gardiner et al. · Journal of Medicinal Chemistry · 2014 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Fused mesoionic heterocycles: synthesis of [1,2,3]triazolo[1,5-a]quinoline, [1,2,3]triazolo[1,5-a]quinazoline, [1,2,3]triazolo[1,5-a]quinoxaline and [1,2,3]triazolo[5,1-c]benzotriazine derivatives

Phillip A. Abbott, Roger V. Bonnert, Moya Caffrey et al. · Tetrahedron · 2002 · 38 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10